» Articles » PMID: 37746720

Moxibustion for the Treatment of Cancer and Its Complications: Efficacies and Mechanisms

Overview
Publisher Sage Publications
Specialties Oncology
Pharmacology
Date 2023 Sep 25
PMID 37746720
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer treatment remains a significant challenge for the medical community, and improved therapies are necessary to treat cancer and its associated complications. Current anticancer therapies often have significant side effects, underscoring the need for new treatment options. Moxibustion is a representative external therapy used in traditional Chinese medicine. This review examines clinical studies demonstrating moxibustion's ability to improve the efficacy of radiotherapy and chemotherapy and control tumor progression. Moxibustion can prevent and treat various complications of cancer, including cancer-related or therapy-induced gastrointestinal symptoms, myelosuppression, fatigue, pain, and postoperative lymphedema. has also been shown to enhance the quality of life for cancer patients. However, very few studies have investigated the underlying mechanisms for these effects, a topic that requires systematic elucidation. Evidence has shown that moxibustion alone or combined with chemotherapy can improve survival and inhibit tumor growth in cancer-bearing animal models. The anticancer effect of moxibustion is associated with alleviating the tumor immunosuppressive and vascular microenvironments. Additionally, the therapeutic effects of moxibustion may originate from the heat and radiation produced during the combustion process on acupoints or lesions. This evidence provides a scientific basis for the clinical application of moxibustion in anticancer treatment and reducing the side effects of cancer therapies and helps promote the precise application of moxibustion in cancer treatment.

References
1.
Cheng C, Deitch J, Haines I, Porter D, Kilbreath S . Do medical procedures in the arm increase the risk of lymphoedema after axillary surgery? A review. ANZ J Surg. 2013; 84(7-8):510-4. DOI: 10.1111/ans.12474. View

2.
Ganesan A, Johansson M, Ruffell B, Yagui-Beltran A, Beltran A, Lau J . Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma. J Immunol. 2013; 191(4):2009-17. PMC: 3774528. DOI: 10.4049/jimmunol.1301317. View

3.
Huang K, Liang S, Hu G, Zou Y, Lu L, Zhang J . [From Biological Effects of Local Cutaneous Thermal Stimulation to Moxibustion Therapy]. Zhen Ci Yan Jiu. 2016; 40(6):504-9. View

4.
Lu M, Wang Y, Yu D, Cao D, Teng Y, Li J . [Effects of acupuncture-moxibustion on contents of IL-12 and TNF-α in spleen of cyclophosphamide- induced cancer-bearing mice]. Zhongguo Zhen Jiu. 2016; 35(11):1145-8. View

5.
Detmar M . Tumor angiogenesis. J Investig Dermatol Symp Proc. 2001; 5(1):20-3. DOI: 10.1046/j.1087-0024.2000.00003.x. View